5th February, 2023
Folasade Akpan
Society for Family Health (SFH), an NGO says women living with HIV and AIDS are six times more likely to develop cervical cancer.
Dr David Oyedeji, Deputy Chief of Party, Key Population Community HIV Care Services for Action Response (KP-CARE 2), made the assertion when he spoke with the News Agency of Nigeria (NAN) on Sunday in Abuja.
According to him, these women face a myriad of challenges that limit their access to cervical cancer screening services ranging from socio-economic, cultural, psychological, and educational.
He described cervical cancer screening as an intervention that helps in the early detection of lesions and identification of pre-cancerous lesions in the cervix prior to treatment.
The methods include Human Papilloma Virus (HPV) screening, PAP smear and Visual Inspection with Acetic acid (VIA).
“Of the three, the VIA is most accessible and cost-effective hence its use in resource-limited settings,” he said.
Oyedeji said that cervical cancer is the fourth most common cancer in the world with more than 600,000 new cases and 340,000 deaths recorded in 2020.
He added that it is the most prevalent gynaecological cancer in Nigeria with more than 60 million women estimated to be at risk.
“Nigeria ranks among the first five countries that represent over half of the global deaths from cervical cancer despite this cancer being largely preventable through screening and vaccination.
“SFH, through the USAID-funded KP CARE 2 project provides cervical cancer screening services for women among key population groups living with HIV and AIDS in Sokoto, Kebbi, Zamfara, Borno, Bauchi, Kebbi and Adamawa,’’ he said.
According to him, the components of the service delivery include community-based education and sensitisation on cervical cancer and facility and community-level screening services.
Other components are immediate treatment services for pre-cancerous lesions identified using cryotherapy or thermalization and partnerships with tertiary health facilities for referral of clients with suspected cancerous lesions for further evaluation and treatment.
Oyedeji said that since the beginning of the KP-CARE 2 project, about 2,000 women had been screened and 30 VIA-positive lesions identified and treated.
Fifteen pre-cancer lesions were also referred for further evaluation and treatment.